MetaVia Inc. — Director's Dealing 2022

Feb 2, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NeuroBo Pharmaceuticals, Inc. (NRBO)
CIK: 0001638287
Period of Report: 2022-01-27

Reporting Person: STRICKLAND D GORDON (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-01-27	Non-qualified Stock Option (right to buy)	$1.02	A	40000	Acquired	2032-01-27	Common Stock (40000)	Direct

Footnotes

F1: Vests in thirty-six equal monthly installments beginning on the one-month anniversary of the date of grant, subject to the reporting person's continued service through each applicable vesting date.